Skip to main content
TipRanks
Go Ultimate75% OFF

Scott Capps Insider Profile

4 Followers

Scott Capps, VP, Clinical Research at Artivion, holds 153.20K shares in Artivion (Ticker: AORT).

Scott Capps's Trading History

AORT
Artivion
Mar 15, 2021VP, Clinical ResearchUninformative Sell34.89K$2.93M
AORT
Insider Shares: 153.20K (0.39%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 15, 2021Uninformative Sell$34.89K1,393$25.05―
Mar 10, 2021Uninformative Sell$5.01K205$24.44―
Feb 25, 2021Uninformative Sell$14.31K563$25.41―
Feb 25, 2021Uninformative Buy$0.003,176$0.00―
Feb 19, 2021Uninformative Buy$0.003,548$0.00―

You May Also Like

Scott Capps insider profile FAQ

What is the percentage of profitable transactions made by Scott Capps?
The percentage of profitable transactions made by Scott Capps is 67%.
What is the average return per transaction made by Scott Capps?
The average return per transaction made by Scott Capps is 0.50%.
What stocks does Scott Capps hold?
Scott Capps holds: AORT stocks.
What was Scott Capps’s latest transaction?
Scott Capps’s latest transaction was an Uninformative Sell of $34.89K.
What was Scott Capps's most profitable transaction?
Scott Capps’s most profitable transaction was an Informative Sell of AORT stock on September 4, 2018. The return on the trade was 24.20%.
What is Scott Capps's role in Artivion?
Scott Capps's role in Artivion is VP, Clinical Research.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.